Document:

CONSENT OF KOST, FORER, GABBAY & KAISIERER

 Exhibit 4(b)(5) 
  
 CONSENT OF INDEPENDENT AUDITORS 
  
 We consent to the incorporation by reference in the Registration Statement on Form S-8 (File Number 333-65904) of our report dated June 29,
2005, with respect to the consolidated financial statements of ViryaNet Ltd. included in its Annual Report on Form 20-F for the year ended December 31, 2004. 
  

			
	Tel-Aviv, Israel	  	KOST, FORER GABBAY and KASIERER
	August 24, 2005	  	A Member of Ernst & Young Global2005 Annual Incentive Compensation Plan

 Exhibit 10.1 
  
 2005 Annual Incentive Compensation Plan, as amended 
  
 The 2005 Annual Incentive Compensation Plan is designed as a team bonus and is not triggered unless the Company meets or
exceeds its budgeted net income and earnings per share for fiscal 2005 (calculated after giving effect to any bonuses accrued under the Compensation Plan). 
  
 The bonus team participants are Fletcher J. McCusker (Chief Executive Officer), Michael N. Deitch (Chief Financial Officer), William Boyd Dover
(President), Craig A. Norris (Chief Operating Officer), Fred D. Furman (General Counsel), Martin J. Favis (Chief Development Officer) and Ms. Mary J. Shea (Executive Vice President of Program Services). 
  
 Individuals of the bonus team are eligible to receive a cash bonus as
follows: (1) if net income and earnings per share exceed budgeted target amounts by 1% to 5%, the cash bonus payable to each individual will be 25% of the individual’s 2005 base salary; and (2) if net income and earnings per share
exceed budgeted target amounts by more than 5%, the cash bonus payable to each individual will be 50% of the individual’s 2005 base salary.Severance Agreement and Release of All Claims

  
 EXHIBIT 10.1

  
 SEVERANCE AGREEMENT 
 AND RELEASE OF ALL CLAIMS 
  

	1.	This Severance Agreement and Release of All Claims (this “Agreement”) is entered into between BioMarin Pharmaceutical Inc., including its officers, directors,
managers, agents, and representatives (“Company”) and Louis Drapeau (“Employee”). The purpose of this Agreement is to arrange a severance of Employee’s employment with Company on a basis that is satisfactory
both to the Company and to Employee. 

  

	2.	Employee’s termination date for all purposes will be October 31, 2005 (“Termination Date”). 

  

	3.	Both Employee and Company are entering into this Agreement as a way of concluding the employment relationship between them and of settling voluntarily any dispute or potential
dispute that Employee has or might have with Company as of the date this Agreement is signed. 

  

	4.	Company agrees to pay to Employee severance pay in the amount of $187,500.00 (thirty-nine weeks salary). Such amount shall be paid in equal installments (other than the first and
the last payment, which will be prorated) of $9,615.40, bi-weekly on every other Friday, commencing on November 11, 2005. All appropriate payroll taxes related to the amounts payable hereunder will be deducted therefrom.

  

	5.	Company agrees to pay for employee to receive the “executive level package” of outplacement services as offered by Right Management. 

  

	6.	The Company agrees that: 

  

	 	6.1.	with respect to the option to purchase 25,000 shares of the Company’s common stock granted to Employee on August 19, 2004, on the Effective Date, in addition to the
vesting that shall normally occur through such date, the right to purchase an additional 4,688 shares shall vest and become exercisable; 

  

	 	6.2.	with respect to the option to purchase 100,000 shares of the Company’s common stock granted to Employee on January 7, 2005, on the Effective Date, in addition to the
vesting that shall normally occur through such date, the right to purchase an additional 18,750 shares shall vest and become exercisable; and 

  

	 	6.3.	with respect to the entire vested portion of both the options described above, including the accelerated vesting portions, the exercise period of such vested options shall be
extended to July 31, 2006; provided that, the extension of the exercise period shall not affect any other term of such options, including, without limitation, the exercise price thereof. 

  

 - 1 - 

	7.	Employee will no longer be eligible to participate in the Company’s Life, Health or Dental Insurance Plans, 401(k) Plan, Short or Long-Term Disability Plans, Educational
Assistance Plan, Employee Stock Purchase Plan, or other employee benefit plans as of the Termination Date. Employee will be eligible for COBRA coverage as required by law. 

  

	8.	As consideration for this severance payment, Employee, for Employee and Employee’s spouse, heirs, executors, representative and assigns, forever releases the Company from any
and all claims, actions, and causes of action which Employee has or might have concerning Employee’s employment with Company or the termination of employment, up to the date of the signing of this Agreement. All such claims are forever barred
by this Agreement and without regard as to whether those claims are based upon any alleged breach of contract or covenant of good faith and fair dealing; any alleged employment discrimination or other unlawful discriminatory acts, including claims
under Title VII, the Fair Employment and Housing Act, the Americans with Disabilities Act, the California Labor Code, the Employee Retirement Income Security Act; the Age Discrimination in Employment Act; the Older Workers Benefit Protection Act of
1990, any alleged tortious act resulting in physical injury, emotional distress, or damage to reputation or other damages; or any other claim or cause of action as of the date of the signing of this Agreement. 

  

	9.	Employee agrees that the foregoing payments, together with all amounts accrued (i.e. for salary and vacation) prior to the Termination Date shall constitute all money and benefits
owed or payable to employee and that Employee will not seek any further compensation for any other claims, damages, costs or attorneys fees. 

  

	10.	The parties acknowledge that California Civil Code Section 1542 provides as follows: 

  
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF
EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR. 
  
 Being fully informed of this provision of the Civil Code, Employee and Company waive any rights under that section, and acknowledge that this Agreement
extends to all claims Employee has or might have against Company, whether known or unknown. 
  

	11.	Employee understands that: 

  

	 	11.1.	Employee has 21 days in which to consider signing this Agreement; 

  

	 	11.2.	Employee should carefully read and fully understand all of the terms of the Agreement; 

  

	 	11.3.	Employee is, through this Agreement, releasing Company from any and all claims Employee may have against it; 

  

 - 2 - 

	 	11.4.	Employee knowingly and voluntarily agrees to all of the terms set forth in this Agreement; 

  

	 	11.5.	Employee knowingly and voluntarily intends to be legally bound by this Agreement; 

  

	 	11.6.	Employee was advised and hereby is advised in writing to consult with an attorney of Employee’s choice prior to signing this Agreement; and 

  

	 	11.7.	Employee has a full seven days following the signing of this Agreement to revoke it and Employee has been, and hereby is, advised in writing that this Agreement will not become
effective or enforceable until that seven-day revocation period has expired and Employee has not revoked the Agreement (“Effective Date”). 

  

	12.	This Agreement is in full satisfaction of disputed claims and by entering into this Agreement, Company is in no way admitting liability of any sort. This Agreement, therefore, does
not constitute an admission of liability of any kind. The Company’s obligations under Section 4 of this Agreement are conditioned on Employee re-executing this Agreement on or within five (5) business days after the Termination
Date. 

  

	13.	Employee will cooperate with requests for information or assistance that the Company may make from time to time up until Employee’s Termination Date. 

 

	14.	Employee agrees that for two (2) years after the Termination Date, Employee will not solicit, hire or encourage the soliciting or hiring of any individual employed by the
Company or any of its subsidiaries. Employee also agrees that for two (2) years after the Termination Date, Employee will not induce any individual employed by the Company or any of its subsidiaries to leave the Company or subsidiary for any
reason whatsoever. 

  

	15.	Employee agrees that Employee will keep the fact, terms and amount of this Agreement completely confidential and that Employee will not disclose any information concerning this
Agreement to anyone except Employee’s counsel. However, Employee may make such disclosures as are required by law and as are necessary for legitimate law enforcement or compliance purposes. Any violation of this provision will terminate the
Company’s obligation under this Agreement. Similarly, the Company agrees to keep the fact, terms and amount of this Agreement completely confidential and that the Company will not disclose any information concerning this Agreement to anyone
outside the Company except Company’s counsel and pertinent accounting and HR professionals. However, Company may make such disclosures as are required by law or as are necessary for legitimate business reasons, law enforcement or compliance
purposes. 

  

	16.	Company will not protest Employee’s claim for unemployment benefits, however, Company reserves the right to review Employee’s reason for termination.

  

	17.	Should any provision of this Agreement be determined by any court to be wholly or partially illegal, invalid or unenforceable, the legality, validity and enforceability of the
remaining provisions shall not be affected, and said illegal, unenforceable or invalid provisions shall be deemed not to be a part of this Agreement. 

  

 - 3 - 

	18.	The Company and Employee agree that any prior communications that may have referenced certain notice and termination benefits, including the Employment Agreement, are superceded by
this Agreement for which good and valuable consideration has been exchanged. 

  

	19.	The parties agree that this document contains their complete and final agreement and that there are no representations, statements, or agreements that have not been included within
this document. 

  

	20.	The parties acknowledge that in signing this Agreement, they do not rely upon and have not relied upon any representation or statement made by any of the parties or their agents
with respect to the subject matter, basis or effect of this Agreement, other than those specifically stated in this written Agreement. 

  

	21.	This Agreement shall be binding upon the parties to this Agreement and upon their heirs, administrators, representatives, executors and assigns. Employee expressly warrants that
Employee has not transferred to any person or entity any rights, causes of action or claims released in this Agreement. 

  

	22.	The parties agree that any dispute regarding the application and interpretation or alleged breach of this Agreement shall be subject to final and binding arbitration before a
neutral arbitrator referred by JAMS/Endispute. That arbitrator shall be selected by the parties from the list of proposed arbitrators referred by JAMS/Endispute. The prevailing party in any such dispute shall be entitled to receive, as a part of the
arbitration award, his/its reasonable attorney’s fees associated with such proceeding. 

  

					
	Louis Drapeau	 	 	 	BioMarin Pharmaceutical Inc.
			
	 /s/ Louis Drapeau
	 	 	 	 /s/ G. Eric Davis

	 Date: August 23, 2004
	 	 	 	 G. Eric Davis, Vice President, Corporate
 Counsel

			
	 	 	 	 	 Date: August 23, 2004

	
	Employee hereby re-executes, and agrees to the terms of, the Agreement, including the release of all claims, as set forth in Section 8 through the date indicated
below.
			
	Louis Drapeau	 	 	 	 
			
	 	 	 	 	 
			
	 Date:
                                       
 
	 	 	 	 

  

 - 4 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]